Supawat Thongthip
Stock Analyst at Truist Financial
(2.70)
# 2,929
Out of 4,703 analysts
12
Total ratings
58.3%
Success rate
8.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $20.07 | +149.13% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Maintained: Buy | $38 | $26.76 | +42.00% | 3 | Aug 12, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | n/a | $20.24 | - | 2 | Aug 7, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | n/a | $29.66 | - | 4 | Aug 6, 2026 |
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $20.07
Upside: +149.13%
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $38
Current: $26.76
Upside: +42.00%
Janux Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $20.24
Upside: -
Arcus Biosciences
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.66
Upside: -